Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascular Risk Using TYG Index in Lupus Nephritis | MicrobiomeTrials← Back to trialsNCT07719322
Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascular Risk Using TYG Index in Lupus Nephritis
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-07Est. Completion: 2028-07
Enrollment target: 156 participants Locations- Assuit university hospitals, Asyut, Assuit, Egypt
Other microbiome trials you might be interested in
Systemic Lupus ErthematosusFatigueExercise Training
Systemic lupus erythematosus, or SLE, is a chronic autoimmune disease that can cause persistent fatigue, muscle pain, re…
Birmingham, United StatesEst. completion Dec 2027
Systemic Lupus Erthematosus (SLE)
To study the effect of anti-inflammatory diet on clinical and biological outcomes in lupus
La Jolla, United StatesEst. completion Jul 1, 2028